PKO Investment Management Joint Stock Co Acquires Shares of 10,500 Danaher Co. (NYSE:DHR)

PKO Investment Management Joint Stock Co bought a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 10,500 shares of the conglomerate's stock, valued at approximately $2,410,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in DHR. LaFleur & Godfrey LLC raised its stake in Danaher by 1.5% in the 4th quarter. LaFleur & Godfrey LLC now owns 29,855 shares of the conglomerate's stock valued at $6,853,000 after purchasing an additional 440 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new position in Danaher in the 4th quarter valued at $74,551,000. Cornerstone Wealth Group LLC raised its stake in Danaher by 9.1% in the 4th quarter. Cornerstone Wealth Group LLC now owns 1,179 shares of the conglomerate's stock valued at $271,000 after purchasing an additional 98 shares during the last quarter. Foundations Investment Advisors LLC raised its stake in Danaher by 41.8% in the 4th quarter. Foundations Investment Advisors LLC now owns 2,321 shares of the conglomerate's stock valued at $533,000 after purchasing an additional 684 shares during the last quarter. Finally, JDH Wealth Management LLC acquired a new position in Danaher in the 4th quarter valued at $304,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Trading Down 0.5%

NYSE DHR traded down $0.93 during trading on Friday, hitting $189.54. The stock had a trading volume of 6,514,078 shares, compared to its average volume of 3,479,894. The company has a market capitalization of $135.65 billion, a PE ratio of 35.90, a PEG ratio of 2.66 and a beta of 0.80. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a 50 day moving average price of $192.72 and a 200 day moving average price of $213.41. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. As a group, equities research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.68%. Danaher's dividend payout ratio is presently 24.85%.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Guggenheim reissued a "buy" rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Robert W. Baird cut their target price on Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. cut their target price on Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Finally, Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price for the company in a research note on Friday, March 14th. Four equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Danaher currently has an average rating of "Moderate Buy" and an average target price of $263.24.

Insider Transactions at Danaher

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.20% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.